The short version
Just 3 companies supply this market — thin enough that a single exit would be felt immediately.
Market view
imatinib · Powder
4 marketed package NDCs · 3 active manufacturers
Most dispensed: MESYLATE 100 mg · Tablet, Film Coated · #30 blister packs/carton / 1 tablet, film coated in 1 blister pack · MESYLATE 400 mg · Tablet, Film Coated · #30 blister packs/carton / 1 tablet, film coated in 1 blister pack · MESYLATE 400 mg · Tablet, Film Coated · #30 tablet, film coateds/bottle, plastic · MESYLATE 100 mg · Tablet, Film Coated · #90 tablet, film coateds/bottle, plastic
What changed in the last 90 days
Every detected change for imatinib, newest first — price moves, shortages, recalls, and manufacturers entering or leaving. Detected by comparing each day’s federal data against the day before.
- ImatinibAug 19, 2026Price downNADAC $2.90376 → $2.87642 per unit (-0.94%)
- ImatinibAug 19, 2026Price downNADAC $0.61767 → $0.61141 per unit (-1.01%)
- Imatinib MesylateAug 19, 2026Price downNADAC $2.90376 → $2.87642 per unit (-0.94%)
- Imatinib MesylateAug 19, 2026Price downNADAC $0.61767 → $0.61141 per unit (-1.01%)
- Imatinib MesylateAug 19, 2026Price downNADAC $2.90376 → $2.87642 per unit (-0.94%)
- Imatinib MesylateAug 19, 2026Price downNADAC $0.61767 → $0.61141 per unit (-1.01%)
- Imatinib MesylateJul 22, 2026Price downNADAC $0.66319 → $0.61767 per unit (-6.86%)
- Imatinib MesylateJul 22, 2026Price downNADAC $0.66319 → $0.61767 per unit (-6.86%)
- ImatinibJul 22, 2026Price downNADAC $0.66319 → $0.61767 per unit (-6.86%)
- ImatinibJul 22, 2026Price downNADAC $2.94835 → $2.90376 per unit (-1.51%)
Same drug class
Other molecules FDA puts in Kinase Inhibitor, with whether each is in shortage right now. Same class is not the same drug — substitution is a clinical decision, and this is a supply picture, not a recommendation.
Common questions
- Is Imatinib in shortage right now?
- No. FDA does not currently list Imatinib in shortage. This page is rebuilt every morning from FDA's shortage database, so a new posting appears here the day it is published.
- Who makes Imatinib?
- 8 companies have marketed Imatinib in the last 30 days, according to the FDA NDC Directory. Every manufacturer and package is listed on this page.
- What does Imatinib cost?
- The typical pharmacy pays about $1.74 per unit, based on the most recent CMS NADAC survey of actual acquisition costs. That is what the pharmacy pays for the drug itself — not the cash price, and not what an insurer is billed.
All marketed products
Expand a strength to see its dosage forms, then package sizes, then each manufacturer and NDC. Click an NDC for its full detail page.